These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 7926071)

  • 1. Surgical treatment and deciding definitive management policy in a premenopausal patient with early breast cancer.
    Rutgers EJ; Peterse JL; Bartelink H; van Dongen JA
    Eur J Surg Oncol; 1994 Oct; 20(5):607-9; discussion 609-10. PubMed ID: 7926071
    [No Abstract]   [Full Text] [Related]  

  • 2. Adjuvant hormonal therapy for premenopausal women with breast cancer.
    Brown RJ; Davidson NE
    Semin Oncol; 2006 Dec; 33(6):657-63. PubMed ID: 17145345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ovarian ablation or suppression in premenopausal early breast cancer: results from the international adjuvant breast cancer ovarian ablation or suppression randomized trial.
    Adjuvant Breast Cancer Trials Collaborative Group
    J Natl Cancer Inst; 2007 Apr; 99(7):516-25. PubMed ID: 17405996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined ovarian ablation and aromatase inhibition as first-line therapy for hormone receptor-positive metastatic breast cancer in premenopausal women: report of three cases.
    El-Saghir NS; El-Hajj II; Makarem JA; Otrock ZK
    Anticancer Drugs; 2006 Sep; 17(8):999-1002. PubMed ID: 16940812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Breast cancer surgery: who chooses and how?
    Margolese RG
    CMAJ; 1994 Feb; 150(3):331-3. PubMed ID: 8293373
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical decision-making in early breast cancer.
    Balch CM; Singletary SE; Bland KI
    Ann Surg; 1993 Mar; 217(3):207-25. PubMed ID: 8383953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Re: Ovarian ablation or suppression in premenopausal early breast cancer: results from the International Adjuvant Breast Cancer Ovarian Ablation or Suppression randomized trial.
    Ferretti G; Felici A; Carlini P; Cognetti F
    J Natl Cancer Inst; 2007 Sep; 99(17):1344-5. PubMed ID: 17728217
    [No Abstract]   [Full Text] [Related]  

  • 8. ACR appropriateness criteria on postmastectomy radiotherapy expert panel on radiation oncology-breast.
    Taylor ME; Haffty BG; Rabinovitch R; Arthur DW; Halberg FE; Strom EA; White JR; Cobleigh MA; Edge SB
    Int J Radiat Oncol Biol Phys; 2009 Mar; 73(4):997-1002. PubMed ID: 19251087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adjuvant treatment in breast cancer. I.
    García-Conde DJ
    Chemioterapia; 1987 Jun; 6(2 Suppl):710. PubMed ID: 3509526
    [No Abstract]   [Full Text] [Related]  

  • 10. The quality of early-stage breast cancer treatment: what can we do to improve?
    Bickell NA; Mendez J; Guth AA
    Surg Oncol Clin N Am; 2005 Jan; 14(1):103-17, vi. PubMed ID: 15542002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of breast cancer.
    Del Mastro L; Venturini M
    N Engl J Med; 1999 Jan; 340(4):319-20. PubMed ID: 9935351
    [No Abstract]   [Full Text] [Related]  

  • 12. Breast-conserving therapy (BCT) for early-stage breast cancer.
    Benda RK; Mendenhall NP; Lind DS; Cendan JC; Shea BF; Richardson LC; Copeland EM
    J Surg Oncol; 2004 Jan; 85(1):14-27. PubMed ID: 14696083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of radiotherapy for ovarian ablation: results of a breast intergroup study.
    Hughes LL; Gray RJ; Solin LJ; Robert NJ; Martino S; Tripathy D; Ingle JN; Wood WC; ; ; ;
    Cancer; 2004 Sep; 101(5):969-72. PubMed ID: 15329905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of breast cancer: what are the trends in 1986?
    Ghys R
    CMAJ; 1986 Jul; 135(1):17-8. PubMed ID: 3719479
    [No Abstract]   [Full Text] [Related]  

  • 15. Adjuvant ovarian suppression versus chemotherapy for premenopausal, hormone-responsive breast cancer: quality of life and efficacy tradeoffs.
    Elkin EB; Weinstein MC; Kuntz KM; Bunnell CA; Weeks JC
    Breast Cancer Res Treat; 2005 Sep; 93(1):25-34. PubMed ID: 16184455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Similar efficacy for ovarian ablation compared with cyclophosphamide, methotrexate, and fluorouracil: from a randomized comparison of premenopausal patients with node-positive, hormone receptor-positive breast cancer.
    Ejlertsen B; Mouridsen HT; Jensen MB; Bengtsson NO; Bergh J; Cold S; Edlund P; Ewertz M; de Graaf PW; Kamby C; Nielsen DL
    J Clin Oncol; 2006 Nov; 24(31):4956-62. PubMed ID: 17075113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preliminary results of electron intraoperative therapy boost and hypofractionated external beam radiotherapy after breast-conserving surgery in premenopausal women.
    Ivaldi GB; Leonardi MC; Orecchia R; Zerini D; Morra A; Galimberti V; Gatti G; Luini A; Veronesi P; Ciocca M; Sangalli C; Fodor C; Veronesi U
    Int J Radiat Oncol Biol Phys; 2008 Oct; 72(2):485-93. PubMed ID: 18407434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surgical and medical management of local-regional treatment failures in advanced primary breast cancer.
    Singletary SE; Hortobagyi GN; Kroll SS
    Surg Oncol Clin N Am; 1995 Oct; 4(4):671-84. PubMed ID: 8535904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ovarian suppression in the management of premenopausal breast cancer: methods and efficacy in adjuvant and metastatic settings.
    McDonald Wade S; Hackney MH; Khatcheressian J; Lyckholm LJ
    Oncology; 2008; 75(3-4):192-202. PubMed ID: 18841034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary systemic therapy in breast cancer: past lessons and new approaches.
    Herold CI; Marcom PK
    Cancer Invest; 2008 Dec; 26(10):1052-9. PubMed ID: 19093262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.